Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
GKEYTFDKZJPLCV
|
6.3 | IC50 | 2 | — | |
GLXUBXYYIZYMLH
|
6.3 | IC50 | 2 | — | |
GMRPXAJENHHBJO
|
6.3 | IC50 | 2 | — | |
GPBYAYDISWNTSP
|
6.3 | IC50 | 2 | — | |
GQSDBTLRASWEQR
|
6.3 | IC50 | 2 | — | |
GXTCLDMNHCXDON
|
6.3 | IC50 | 2 | — | |
HADRIGGJOASIFL
|
6.3 | IC50 | 2 | — | |
HFYCMSYPZDIZRL
|
6.3 | IC50 | 2 | — | |
HMIBAGKTOBTRMK
|
6.3 | IC50 | 2 | — | |
HMIBAGKTOBTRMK
|
6.3 | IC50 | 2 | — | |
HRTNJUDCXNKSRX
|
6.3 | IC50 | 2 | — | |
HYENYGCYRWPCKN
|
6.3 | IC50 | 2 | — | |
IBHKNTWKKFMFAY
|
6.3 | IC50 | 2 | — | |
IGBPTTZJSDQIHG
|
6.3 | IC50 | 2 | — | |
IGPNXQSRPFWPHR
|
6.3 | IC50 | 2 | — | |
IGPNXQSRPFWPHR
|
6.3 | IC50 | 2 | — | |
IGPNXQSRPFWPHR
|
6.3 | IC50 | 2 | — | |
IHSGSUHZKPVHHY
|
6.3 | IC50 | 2 | — | |
IHTWOQGRIRZNOM
|
6.3 | IC50 | 2 | — | |
IHTWOQGRIRZNOM
|
6.3 | IC50 | 2 | — | |
IINRADPLSNKLSD
|
6.3 | IC50 | 2 | — | |
IMWBOZFPYIXJGC
|
6.3 | IC50 | 2 | — | |
IOAUFAAKRVGQON
|
6.3 | IC50 | 2 | — | |
IOAUFAAKRVGQON
|
6.3 | IC50 | 2 | — | |
ISXGTFFPUGECBV
|
6.3 | IC50 | 2 | — | |
ITFFBPGQPZIVAW
|
6.3 | IC50 | 2 | — | |
IUSXYFZTDTXGHW
|
6.3 | IC50 | 2 | — | |
IXFVALRLFCEAQS
|
6.3 | IC50 | 2 | — | |
IXFVALRLFCEAQS
|
6.3 | IC50 | 2 | — | |
IYLCJIDEKPPDDO
|
6.3 | IC50 | 2 | — | |
JCYJULQVESXQTK
|
6.3 | IC50 | 2 | — | |
JEWQADOHABYOIM
|
6.3 | IC50 | 2 | — | |
JKBHRMOQZGEAIS
|
6.3 | IC50 | 2 | — | |
JKBHRMOQZGEAIS
|
6.3 | IC50 | 2 | — | |
JKMUIIXZCFNZSY
|
6.3 | IC50 | 2 | — | |
JNLSQIXOTMUQCX
|
6.3 | IC50 | 2 | — | |
JQBBCMCZWXBQPD
|
6.3 | IC50 | 2 | — | |
JQDZNGNMSSTDKG
|
6.3 | IC50 | 2 | — | |
JQELOTWBVNBCOV
|
6.3 | IC50 | 2 | — | |
JQTCVTWPSKIYFX
|
6.3 | IC50 | 2 | — | |
JUKOUBOFUKWDQD
|
6.3 | IC50 | 2 | — | |
JXPFRWACDWADBT
|
6.3 | IC50 | 2 | — | |
JYGPOVAHCAESFT
|
6.3 | IC50 | 2 | — | |
JYZKFNNCRRJCBS
|
6.3 | IC50 | 2 | — | |
KHENLVHRUAKHRG
|
6.3 | IC50 | 2 | — | |
KHENLVHRUAKHRG
|
6.3 | IC50 | 2 | — | |
KITBLDJCPYXISG
|
6.3 | IC50 | 2 | — | |
KITBLDJCPYXISG
|
6.3 | IC50 | 2 | — | |
KNVJDUBGSCNYGN
|
6.3 | IC50 | 2 | — | |
KOWKLERPUHXGFH
|
6.3 | IC50 | 2 | — |